Viewing nowCombinationKoroza Plus Tablets
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.

MFDS item code 201207577 · Approved 2012.10.31 · Insurance code 698502230
Treatment of hypertension not controlled with monotherapy
This medication is used additionally in patients with hypertension for whom blood pressure control is insufficient with monotherapy, helping to effectively lower blood pressure.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs approximately 3 weeks after starting treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start treatment with this medicine only when the expected effect has not been achieved with monotherapy. 1. Substitution therapy: A regimen of dose-adjusted losartan potassium and hydrochlorothiazide administered concomitantly as separate products may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia despite blood pressure control at this dose: Treatment may be initiated with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which reduces the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. The clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should then be monitored continuously; if blood pressure remains uncontrolled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose may be administered when creatinine clearance is 30 mL/min or higher. Administration is not recommended in patients with more severe renal impairment, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Administration is not recommended in patients with hepatic impairment requiring dose adjustment, since the initial dose of losartan potassium for such patients, 25 mg, cannot be administered using this product.
Children (under 18 years): Since there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be immediately discontinued upon confirmation of pregnancy. This medication should not be administered to patients with certain allergies, severely impaired renal function, severe liver disorder, pregnant women or those who could become pregnant, and patients with certain genetic metabolic disorders. Caution is required when using this medication in patients with low blood pressure, decreased kidney function, liver disease, diabetes, or gout. Particularly in the elderly, adverse reactions may occur more frequently, warranting careful monitoring. This medication lowers blood pressure, which may cause dizziness or drowsiness; caution should be exercised when driving or operating machinery. During treatment with this medication, electrolyte status and kidney function should be monitored regularly through blood tests, and care should be taken to prevent potassium levels from becoming too high or too low. This medication may interact with other drugs, so it is essential to consult with a physician or pharmacist, especially if potassium supplements, potassium-sparing diuretics, certain diuretics, antihypertensive medications, or non-steroidal anti-inflammatory drugs are being used. The Hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer; therefore, it is important to avoid sun exposure and take protective measures. If symptoms such as sudden vision changes, eye pain, severe rash, or difficulty breathing occur during treatment with this medication, immediate medical attention should be sought. Women who are pregnant or planning to become pregnant should consult with a physician before taking this medication, and breastfeeding women should also be cautious as this medication may pass into breast milk. Safety and effectiveness have not been established for children and adolescents, therefore this medication should not be administered to them. In cases of overdose, symptoms such as hypotension and heart rhythm disturbances may occur; if these symptoms appear, immediate consultation with healthcare professionals is necessary, and this medication cannot be removed by hemodialysis, requiring specialized treatment. This medication should be kept out of the reach of children, and stored in its original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a tightly closed container that blocks light. Additionally, it is important to store it at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.
Yellow oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.